Fas apoptosis inhibitory molecules: more than death‐receptor antagonists in the nervous system

The importance of death receptor (DR) signaling in embryonic development and physiological homeostasis is well established, as is the existence of several molecules that modulate DRs function, among them Fas Apoptotis Inhibitory Molecules. Although FAIM1, FAIM2, and FAIM3 inhibit Fas‐induced cell de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurochemistry 2016-10, Vol.139 (1), p.11-21
Hauptverfasser: Planells‐Ferrer, Laura, Urresti, Jorge, Coccia, Elena, Galenkamp, Koen M. O., Calleja‐Yagüe, Isabel, López‐Soriano, Joaquín, Carriba, Paulina, Barneda‐Zahonero, Bruna, Segura, Miguel F., Comella, Joan X.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 21
container_issue 1
container_start_page 11
container_title Journal of neurochemistry
container_volume 139
creator Planells‐Ferrer, Laura
Urresti, Jorge
Coccia, Elena
Galenkamp, Koen M. O.
Calleja‐Yagüe, Isabel
López‐Soriano, Joaquín
Carriba, Paulina
Barneda‐Zahonero, Bruna
Segura, Miguel F.
Comella, Joan X.
description The importance of death receptor (DR) signaling in embryonic development and physiological homeostasis is well established, as is the existence of several molecules that modulate DRs function, among them Fas Apoptotis Inhibitory Molecules. Although FAIM1, FAIM2, and FAIM3 inhibit Fas‐induced cell death, they are not structurally related, nor do they share expression patterns. Moreover, they inhibit apoptosis through completely different mechanisms. FAIM1 and FAIM2 protect neurons from DR‐induced apoptosis and are involved in neurite outgrowth and neuronal plasticity. FAIM1 inhibits Fas ligand‐ and tumor necrosis factor alpha‐induced apoptosis by direct interaction with Fas receptor and through the stabilization of levels of X‐linked inhibitor of apoptosis protein, a potent anti‐apoptotic protein that inhibits caspases. Low FAIM1 levels are found in Alzheimer's disease, thus sensitizing neurons to tumor necrosis factor alpha and prompting neuronal loss. FAIM2 protects from Fas by direct interaction with Fas receptor, as well as by modulating calcium release at the endoplasmic reticulum through interaction with Bcl‐xL. Several studies prove the role of FAIM2 in diseases of the nervous system, such as ischemia, bacterial meningitis, and neuroblastoma. The less characterized member of the FAIM family is FAIM3, which is expressed in tissues of the digestive and urinary tracts, bone marrow and testes, and restricted to the cerebellum in the nervous system. FAIM3 protects against DR‐induced apoptosis by inducing the expression of other DR‐antagonists such as CFLAR or through the interaction with the DR‐adaptor protein Fas‐associated via death domain. FAIM3 null mouse models reveal this protein as an important mediator of inflammatory autoimmune responses such as those triggered in autoimmune encephalomyelitis. Given the differences between FAIMs and the variety of processes in which they are involved, here we sought to provide a concise review about these molecules and their roles in the physiology and pathology of the nervous system. Even though they share name and inhibit Fas‐induced cell death, Fas apoptotic inhibitory molecules (FAIMs) are not structurally related and inhibit apoptosis through completely different mechanisms. In this review, we describe FAIM1, FAIM2, and FAIM3 functions in the nervous system, and their implication in diverse pathologies such as neurodegenerative disease, cancer, or autoimmune diseases. Even though they share name and inhibit
doi_str_mv 10.1111/jnc.13729
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1827885046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1823907970</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4219-b644af3d54a846f30124529c53270339c72e6cc7c6c5c827a944f182383290a13</originalsourceid><addsrcrecordid>eNqN0btOwzAUBmALgWgpDLwAisQCQ1rfEttsqKJcVMECc3DdE5oqiYudgLrxCDwjT4JLCwMSEl7s4Tu_bf0IHRLcJ2EN5rXpEyao2kJdwgWJOUnUNupiTGnMMKcdtOf9HGOS8pTsog4VTCacqS56HGkf6YVdNNYXPirqWTEpGuuWUWVLMG0J_iwcHUTNTNfRFHQz-3h7d2AgjLhI141-snXhm9VwQBDV4F5s6yO_9A1U-2gn16WHg83eQw-ji_vhVTy-u7weno9jwylR8STlXOdsmnAteZozTChPqDIJowIzpoygkBojTGoSI6nQivOcSMokowprwnroZJ27cPa5Bd9kVeENlKWuIbwmC1ZImWCe_ocyhYUKF_fQ8S86t62rw0dWikqVJlwGdbpWxlnvHeTZwhWVdsuM4GzVUBYayr4aCvZok9hOKpj-yO9KAhiswWtRwvLvpOzmdriO_ARG6pnx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1822896548</pqid></control><display><type>article</type><title>Fas apoptosis inhibitory molecules: more than death‐receptor antagonists in the nervous system</title><source>Wiley Free Content</source><source>MEDLINE</source><source>IngentaConnect Free/Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Planells‐Ferrer, Laura ; Urresti, Jorge ; Coccia, Elena ; Galenkamp, Koen M. O. ; Calleja‐Yagüe, Isabel ; López‐Soriano, Joaquín ; Carriba, Paulina ; Barneda‐Zahonero, Bruna ; Segura, Miguel F. ; Comella, Joan X.</creator><creatorcontrib>Planells‐Ferrer, Laura ; Urresti, Jorge ; Coccia, Elena ; Galenkamp, Koen M. O. ; Calleja‐Yagüe, Isabel ; López‐Soriano, Joaquín ; Carriba, Paulina ; Barneda‐Zahonero, Bruna ; Segura, Miguel F. ; Comella, Joan X.</creatorcontrib><description>The importance of death receptor (DR) signaling in embryonic development and physiological homeostasis is well established, as is the existence of several molecules that modulate DRs function, among them Fas Apoptotis Inhibitory Molecules. Although FAIM1, FAIM2, and FAIM3 inhibit Fas‐induced cell death, they are not structurally related, nor do they share expression patterns. Moreover, they inhibit apoptosis through completely different mechanisms. FAIM1 and FAIM2 protect neurons from DR‐induced apoptosis and are involved in neurite outgrowth and neuronal plasticity. FAIM1 inhibits Fas ligand‐ and tumor necrosis factor alpha‐induced apoptosis by direct interaction with Fas receptor and through the stabilization of levels of X‐linked inhibitor of apoptosis protein, a potent anti‐apoptotic protein that inhibits caspases. Low FAIM1 levels are found in Alzheimer's disease, thus sensitizing neurons to tumor necrosis factor alpha and prompting neuronal loss. FAIM2 protects from Fas by direct interaction with Fas receptor, as well as by modulating calcium release at the endoplasmic reticulum through interaction with Bcl‐xL. Several studies prove the role of FAIM2 in diseases of the nervous system, such as ischemia, bacterial meningitis, and neuroblastoma. The less characterized member of the FAIM family is FAIM3, which is expressed in tissues of the digestive and urinary tracts, bone marrow and testes, and restricted to the cerebellum in the nervous system. FAIM3 protects against DR‐induced apoptosis by inducing the expression of other DR‐antagonists such as CFLAR or through the interaction with the DR‐adaptor protein Fas‐associated via death domain. FAIM3 null mouse models reveal this protein as an important mediator of inflammatory autoimmune responses such as those triggered in autoimmune encephalomyelitis. Given the differences between FAIMs and the variety of processes in which they are involved, here we sought to provide a concise review about these molecules and their roles in the physiology and pathology of the nervous system. Even though they share name and inhibit Fas‐induced cell death, Fas apoptotic inhibitory molecules (FAIMs) are not structurally related and inhibit apoptosis through completely different mechanisms. In this review, we describe FAIM1, FAIM2, and FAIM3 functions in the nervous system, and their implication in diverse pathologies such as neurodegenerative disease, cancer, or autoimmune diseases. Even though they share name and inhibit Fas‐induced cell death, Fas apoptotic inhibitory molecules (FAIMs) are not structurally related and inhibit apoptosis through completely different mechanisms. In this review, we describe FAIM1, FAIM2, and FAIM3 functions in the nervous system, and their implication in diverse pathologies such as neurodegenerative disease, cancer, or autoimmune diseases.</description><identifier>ISSN: 0022-3042</identifier><identifier>EISSN: 1471-4159</identifier><identifier>DOI: 10.1111/jnc.13729</identifier><identifier>PMID: 27385439</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Alzheimer's disease ; Animals ; Apoptosis ; Apoptosis - drug effects ; Apoptosis Regulatory Proteins - genetics ; Cell Death - drug effects ; Cell Death - genetics ; FAIM ; fas Receptor - antagonists &amp; inhibitors ; fas Receptor - genetics ; Gangrene ; Humans ; lifeguard ; Mice ; Nervous System ; Proteins ; TOSO ; Tumor necrosis factor-TNF</subject><ispartof>Journal of neurochemistry, 2016-10, Vol.139 (1), p.11-21</ispartof><rights>2016 International Society for Neurochemistry</rights><rights>2016 International Society for Neurochemistry.</rights><rights>Copyright © 2016 International Society for Neurochemistry</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4219-b644af3d54a846f30124529c53270339c72e6cc7c6c5c827a944f182383290a13</citedby><cites>FETCH-LOGICAL-c4219-b644af3d54a846f30124529c53270339c72e6cc7c6c5c827a944f182383290a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjnc.13729$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjnc.13729$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27385439$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Planells‐Ferrer, Laura</creatorcontrib><creatorcontrib>Urresti, Jorge</creatorcontrib><creatorcontrib>Coccia, Elena</creatorcontrib><creatorcontrib>Galenkamp, Koen M. O.</creatorcontrib><creatorcontrib>Calleja‐Yagüe, Isabel</creatorcontrib><creatorcontrib>López‐Soriano, Joaquín</creatorcontrib><creatorcontrib>Carriba, Paulina</creatorcontrib><creatorcontrib>Barneda‐Zahonero, Bruna</creatorcontrib><creatorcontrib>Segura, Miguel F.</creatorcontrib><creatorcontrib>Comella, Joan X.</creatorcontrib><title>Fas apoptosis inhibitory molecules: more than death‐receptor antagonists in the nervous system</title><title>Journal of neurochemistry</title><addtitle>J Neurochem</addtitle><description>The importance of death receptor (DR) signaling in embryonic development and physiological homeostasis is well established, as is the existence of several molecules that modulate DRs function, among them Fas Apoptotis Inhibitory Molecules. Although FAIM1, FAIM2, and FAIM3 inhibit Fas‐induced cell death, they are not structurally related, nor do they share expression patterns. Moreover, they inhibit apoptosis through completely different mechanisms. FAIM1 and FAIM2 protect neurons from DR‐induced apoptosis and are involved in neurite outgrowth and neuronal plasticity. FAIM1 inhibits Fas ligand‐ and tumor necrosis factor alpha‐induced apoptosis by direct interaction with Fas receptor and through the stabilization of levels of X‐linked inhibitor of apoptosis protein, a potent anti‐apoptotic protein that inhibits caspases. Low FAIM1 levels are found in Alzheimer's disease, thus sensitizing neurons to tumor necrosis factor alpha and prompting neuronal loss. FAIM2 protects from Fas by direct interaction with Fas receptor, as well as by modulating calcium release at the endoplasmic reticulum through interaction with Bcl‐xL. Several studies prove the role of FAIM2 in diseases of the nervous system, such as ischemia, bacterial meningitis, and neuroblastoma. The less characterized member of the FAIM family is FAIM3, which is expressed in tissues of the digestive and urinary tracts, bone marrow and testes, and restricted to the cerebellum in the nervous system. FAIM3 protects against DR‐induced apoptosis by inducing the expression of other DR‐antagonists such as CFLAR or through the interaction with the DR‐adaptor protein Fas‐associated via death domain. FAIM3 null mouse models reveal this protein as an important mediator of inflammatory autoimmune responses such as those triggered in autoimmune encephalomyelitis. Given the differences between FAIMs and the variety of processes in which they are involved, here we sought to provide a concise review about these molecules and their roles in the physiology and pathology of the nervous system. Even though they share name and inhibit Fas‐induced cell death, Fas apoptotic inhibitory molecules (FAIMs) are not structurally related and inhibit apoptosis through completely different mechanisms. In this review, we describe FAIM1, FAIM2, and FAIM3 functions in the nervous system, and their implication in diverse pathologies such as neurodegenerative disease, cancer, or autoimmune diseases. Even though they share name and inhibit Fas‐induced cell death, Fas apoptotic inhibitory molecules (FAIMs) are not structurally related and inhibit apoptosis through completely different mechanisms. In this review, we describe FAIM1, FAIM2, and FAIM3 functions in the nervous system, and their implication in diverse pathologies such as neurodegenerative disease, cancer, or autoimmune diseases.</description><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis Regulatory Proteins - genetics</subject><subject>Cell Death - drug effects</subject><subject>Cell Death - genetics</subject><subject>FAIM</subject><subject>fas Receptor - antagonists &amp; inhibitors</subject><subject>fas Receptor - genetics</subject><subject>Gangrene</subject><subject>Humans</subject><subject>lifeguard</subject><subject>Mice</subject><subject>Nervous System</subject><subject>Proteins</subject><subject>TOSO</subject><subject>Tumor necrosis factor-TNF</subject><issn>0022-3042</issn><issn>1471-4159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0btOwzAUBmALgWgpDLwAisQCQ1rfEttsqKJcVMECc3DdE5oqiYudgLrxCDwjT4JLCwMSEl7s4Tu_bf0IHRLcJ2EN5rXpEyao2kJdwgWJOUnUNupiTGnMMKcdtOf9HGOS8pTsog4VTCacqS56HGkf6YVdNNYXPirqWTEpGuuWUWVLMG0J_iwcHUTNTNfRFHQz-3h7d2AgjLhI141-snXhm9VwQBDV4F5s6yO_9A1U-2gn16WHg83eQw-ji_vhVTy-u7weno9jwylR8STlXOdsmnAteZozTChPqDIJowIzpoygkBojTGoSI6nQivOcSMokowprwnroZJ27cPa5Bd9kVeENlKWuIbwmC1ZImWCe_ocyhYUKF_fQ8S86t62rw0dWikqVJlwGdbpWxlnvHeTZwhWVdsuM4GzVUBYayr4aCvZok9hOKpj-yO9KAhiswWtRwvLvpOzmdriO_ARG6pnx</recordid><startdate>201610</startdate><enddate>201610</enddate><creator>Planells‐Ferrer, Laura</creator><creator>Urresti, Jorge</creator><creator>Coccia, Elena</creator><creator>Galenkamp, Koen M. O.</creator><creator>Calleja‐Yagüe, Isabel</creator><creator>López‐Soriano, Joaquín</creator><creator>Carriba, Paulina</creator><creator>Barneda‐Zahonero, Bruna</creator><creator>Segura, Miguel F.</creator><creator>Comella, Joan X.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201610</creationdate><title>Fas apoptosis inhibitory molecules: more than death‐receptor antagonists in the nervous system</title><author>Planells‐Ferrer, Laura ; Urresti, Jorge ; Coccia, Elena ; Galenkamp, Koen M. O. ; Calleja‐Yagüe, Isabel ; López‐Soriano, Joaquín ; Carriba, Paulina ; Barneda‐Zahonero, Bruna ; Segura, Miguel F. ; Comella, Joan X.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4219-b644af3d54a846f30124529c53270339c72e6cc7c6c5c827a944f182383290a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis Regulatory Proteins - genetics</topic><topic>Cell Death - drug effects</topic><topic>Cell Death - genetics</topic><topic>FAIM</topic><topic>fas Receptor - antagonists &amp; inhibitors</topic><topic>fas Receptor - genetics</topic><topic>Gangrene</topic><topic>Humans</topic><topic>lifeguard</topic><topic>Mice</topic><topic>Nervous System</topic><topic>Proteins</topic><topic>TOSO</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Planells‐Ferrer, Laura</creatorcontrib><creatorcontrib>Urresti, Jorge</creatorcontrib><creatorcontrib>Coccia, Elena</creatorcontrib><creatorcontrib>Galenkamp, Koen M. O.</creatorcontrib><creatorcontrib>Calleja‐Yagüe, Isabel</creatorcontrib><creatorcontrib>López‐Soriano, Joaquín</creatorcontrib><creatorcontrib>Carriba, Paulina</creatorcontrib><creatorcontrib>Barneda‐Zahonero, Bruna</creatorcontrib><creatorcontrib>Segura, Miguel F.</creatorcontrib><creatorcontrib>Comella, Joan X.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Planells‐Ferrer, Laura</au><au>Urresti, Jorge</au><au>Coccia, Elena</au><au>Galenkamp, Koen M. O.</au><au>Calleja‐Yagüe, Isabel</au><au>López‐Soriano, Joaquín</au><au>Carriba, Paulina</au><au>Barneda‐Zahonero, Bruna</au><au>Segura, Miguel F.</au><au>Comella, Joan X.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fas apoptosis inhibitory molecules: more than death‐receptor antagonists in the nervous system</atitle><jtitle>Journal of neurochemistry</jtitle><addtitle>J Neurochem</addtitle><date>2016-10</date><risdate>2016</risdate><volume>139</volume><issue>1</issue><spage>11</spage><epage>21</epage><pages>11-21</pages><issn>0022-3042</issn><eissn>1471-4159</eissn><abstract>The importance of death receptor (DR) signaling in embryonic development and physiological homeostasis is well established, as is the existence of several molecules that modulate DRs function, among them Fas Apoptotis Inhibitory Molecules. Although FAIM1, FAIM2, and FAIM3 inhibit Fas‐induced cell death, they are not structurally related, nor do they share expression patterns. Moreover, they inhibit apoptosis through completely different mechanisms. FAIM1 and FAIM2 protect neurons from DR‐induced apoptosis and are involved in neurite outgrowth and neuronal plasticity. FAIM1 inhibits Fas ligand‐ and tumor necrosis factor alpha‐induced apoptosis by direct interaction with Fas receptor and through the stabilization of levels of X‐linked inhibitor of apoptosis protein, a potent anti‐apoptotic protein that inhibits caspases. Low FAIM1 levels are found in Alzheimer's disease, thus sensitizing neurons to tumor necrosis factor alpha and prompting neuronal loss. FAIM2 protects from Fas by direct interaction with Fas receptor, as well as by modulating calcium release at the endoplasmic reticulum through interaction with Bcl‐xL. Several studies prove the role of FAIM2 in diseases of the nervous system, such as ischemia, bacterial meningitis, and neuroblastoma. The less characterized member of the FAIM family is FAIM3, which is expressed in tissues of the digestive and urinary tracts, bone marrow and testes, and restricted to the cerebellum in the nervous system. FAIM3 protects against DR‐induced apoptosis by inducing the expression of other DR‐antagonists such as CFLAR or through the interaction with the DR‐adaptor protein Fas‐associated via death domain. FAIM3 null mouse models reveal this protein as an important mediator of inflammatory autoimmune responses such as those triggered in autoimmune encephalomyelitis. Given the differences between FAIMs and the variety of processes in which they are involved, here we sought to provide a concise review about these molecules and their roles in the physiology and pathology of the nervous system. Even though they share name and inhibit Fas‐induced cell death, Fas apoptotic inhibitory molecules (FAIMs) are not structurally related and inhibit apoptosis through completely different mechanisms. In this review, we describe FAIM1, FAIM2, and FAIM3 functions in the nervous system, and their implication in diverse pathologies such as neurodegenerative disease, cancer, or autoimmune diseases. Even though they share name and inhibit Fas‐induced cell death, Fas apoptotic inhibitory molecules (FAIMs) are not structurally related and inhibit apoptosis through completely different mechanisms. In this review, we describe FAIM1, FAIM2, and FAIM3 functions in the nervous system, and their implication in diverse pathologies such as neurodegenerative disease, cancer, or autoimmune diseases.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>27385439</pmid><doi>10.1111/jnc.13729</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3042
ispartof Journal of neurochemistry, 2016-10, Vol.139 (1), p.11-21
issn 0022-3042
1471-4159
language eng
recordid cdi_proquest_miscellaneous_1827885046
source Wiley Free Content; MEDLINE; IngentaConnect Free/Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry
subjects Alzheimer's disease
Animals
Apoptosis
Apoptosis - drug effects
Apoptosis Regulatory Proteins - genetics
Cell Death - drug effects
Cell Death - genetics
FAIM
fas Receptor - antagonists & inhibitors
fas Receptor - genetics
Gangrene
Humans
lifeguard
Mice
Nervous System
Proteins
TOSO
Tumor necrosis factor-TNF
title Fas apoptosis inhibitory molecules: more than death‐receptor antagonists in the nervous system
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T00%3A13%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fas%20apoptosis%20inhibitory%20molecules:%20more%20than%20death%E2%80%90receptor%20antagonists%20in%20the%20nervous%20system&rft.jtitle=Journal%20of%20neurochemistry&rft.au=Planells%E2%80%90Ferrer,%20Laura&rft.date=2016-10&rft.volume=139&rft.issue=1&rft.spage=11&rft.epage=21&rft.pages=11-21&rft.issn=0022-3042&rft.eissn=1471-4159&rft_id=info:doi/10.1111/jnc.13729&rft_dat=%3Cproquest_cross%3E1823907970%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1822896548&rft_id=info:pmid/27385439&rfr_iscdi=true